Diagnostic information technology company Sunquest is calling on fellow industry leaders and stakeholders to encourage the Food and Drug Administration (FDA) to regulate the emerging field of Health Information Technology (HIT).
Regulation is key to driving innovation, Sunquest says, which can help improve patient safety outcomes and move the field forward. The HIT Group will pursue its goals through letters to the FDA and communication with the United States Department of Health and Human Services. Members will also receive updates on the group’s progress via webinars and shared best practices.
Interested parties should contact Sunquest’s vice president of client experience, Patrice JC Nedelec, to add their company name to a list of members. For more information, visit The Hit Group.
